Skip to main content
SpringerLink
Log in

Pathogénie et épidémiologie de l’hypertension artérielle

Pathogenesis and Epidemiology of Arterial Hypertension

  • Review Article
  • Published:
Drugs Aims and scope Submit manuscript

Résumé

La pathogénie de l’hypertension artérielle (HTA) essentielle est mieux connue aujourd’hui grâce aux données récentes qui ont permis d’identifier d’une part, des facteurs génétiques et d’autre part, des facteurs environnementaux, notamment poids corporel, consommation d’alcool, exercice physique, tabagisme et consommation de sel ainsi que le régime alimentaire en général.

Par ailleurs, le poids global de l’HTA est évalué en tenant compte de l’impact de cette maladie en termes de prévalence, de complications associées et de son coût social. En ce qui concerne les complications liées à l’hypertension, les auteurs présentent une réactualisation des données concernant les accidents vasculaires cérébraux, l’insuffisance cardiaque, les cardiopathies d’origine coronarienne et les artériopathies périphériques.

Les risques individuels sont comparés aux risques collectifs et les risques relatifs aux risques absolus. Des propositions sont avancées quant à l’intérêt de leur utilisation en pratique clinique.

Abstract

The pathogenesis of arterial hypertension is more clearly understood today because of the availability of data enabling identification of a certain number of precipitating factors. From a genetic standpoint, hypertension would appear to be a multifactorial polygenic disorder with a tendency to interact with certain environmental factors. The latter are mainly related to lifestyle and are potentially modifiable.

Obesity during childhood and adolescence is the main predictive factor for hypertension. It has been suggested that the underlying mechanism could well be hyperinsulinaemia, which induces hyperactivity of the sympathetic nervous system.

The mechanisms of the relationship between hypertension and alcohol are still unclear. However, in many countries, excessive alcohol consumption has been reported to be a significant factor in the development of arterial hypertension.

The negative effect of a sedentary lifestyle on blood pressure has been widely demonstrated. In addition, it has also been shown that regular physical exercise under aerobic conditions leads to a reduction in blood pressure levels. An excessive sodium intake is also responsible for inducing arterial hypertension through increases in cardiac output and effects on vascular reactivity and contractility. Similarly, restricting sodium intake leads to a reduction in blood pressure levels.

Smoking — namely, certain components of tobacco smoke — would appear to have both short and long term effects on blood pressure.

These contributing factors all have specific effects on cardiac output and peripheral resistance in individuals.

At the community level, the impact of hypertension is particularly significant. Prevalence is strongly influenced by the type of population studied, although it is generally estimated that this disease affects between 10 and 20% of the adult population and is responsible for 5.8% of all deaths worldwide. The direct and indirect costs of the disease are particularly high and are generally considered to be underestimated since a significant proportion of cardiac disease and stroke should also be included in any cost estimates, giving extremely high final figures.

Hypertension-related morbidity and mortality principally result from cardiovascular complications and approximately 35% of atherosclerotic cardiovascular events can be attributed to hypertension. The highest risks are associated with stroke (relative risk: 3.8) and congestive heart failure in individuals with hypertension, in whom the risk is quadrupled.

With regard to risk for an individual, the higher the blood pressure the greater the risk for the patient. However, the situation is very different if the entire population is being considered. In this instance, the highest risk is associated with mild hypertension since this involves the largest proportion of the hypertensive population.

Similarly, relative risk corresponds to a probability rate that applies to populations rather than individuals. In response to this contradiction, the concept of absolute risk was proposed and corresponds to the prevalence of the disease.

The approach to hypertension treatment based on absolute risk has recently been proposed for use in clinical practice. It takes into account lesions of the target organ together with any other risk factors and thus integrates the notion of prevention which remains the principal approach to the problems encountered in the management of hypertension.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med 1997; 157: 2413–46

    Google Scholar 

  2. Paffenbarger Jr RS, Thorne MC, Wing AL. Chronic disease in former college students. VIII. Characteristics in youth predisposing to hypertension in later years. Am J Epidemiol 1986; 88: 25–32

    Google Scholar 

  3. Tuck ML. Obesity. In: Swales JD, editor. Textbook of hypertension. Oxford: Blackwell Scientific Publications, 1994: 576–92

    Google Scholar 

  4. Kaplan NM. The deadly quartet: upper body obesity, glucose intolerance, hypertriglyceridaemia and hypertension. Arch Intern Med 1989; 149: 1514–20

    Article  PubMed  CAS  Google Scholar 

  5. Klatsky AL, Friedman GD, Armstrong MA. The relationships between alcoholic beverage use and other traits to blood pressure: a new Kaiser Permanente study. Circulation 1986; 73: 628–36

    Article  PubMed  CAS  Google Scholar 

  6. Vandongen R, Puddey IB. Alcohol intake and blood pressure. In: Swales JD, editor. Textbook of hypertension. Oxford: Blackwell Scientific Publications, 1994: 567–75

    Google Scholar 

  7. Blair SN, Goodyear NN, Gibbons LW, et al. Physical fitness and incidence of hypertension in healthy normotensive men and women. JAMA 1984; 252: 487–90

    Article  PubMed  CAS  Google Scholar 

  8. World Hypertension League. Physical exercise in the management of hypertension. A consensus statement by the World Hypertension League. J Hypertens 1991; 9: 283–7

    Article  Google Scholar 

  9. Fagard R, Bielen P, Hespel P, et al. Physical exercise in hypertension. In: Laragh JH, Brenner BM, editors. Hypertension: pathophysiology, diagnosis and management. New York: Raven Press, 1990: 1985–98

    Google Scholar 

  10. Dahl LK. Possible role of salt intake in the development of essential hypertension. In: Bock KD, Cottier P, editors. Essential hypertension: an international symposium. Berlin: Springer Verlag, 1960: 61–75

    Google Scholar 

  11. Elliott P. Observational studies of salt and blood pressure. Hypertension 1991; 17 (1 Suppl.): I3-I8

    Google Scholar 

  12. Intersalt Cooperative Research Group. Intersalt: an international study of electrolyte excretion and blood pressure: results for 24 hour urinary sodium and potassium excretion. BMJ 1988; 297: 319–28

    Article  Google Scholar 

  13. Weinberger MH, Miller JZ, Luft FC, et al. Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension 1986; 8 (6 Pt 2): II127–34

    PubMed  CAS  Google Scholar 

  14. Grobbee DE, Hofman A. Does sodium restriction lower blood pressure? BMJ 1986; 293: 27–9

    Article  PubMed  CAS  Google Scholar 

  15. Cutler JA, Follmann D, Elliot P, et al. An overview of randomized trials of sodium reduction and blood pressure. Hypertension 1991; 17 Suppl. I: I27-I33

    Google Scholar 

  16. Report of a WHO Expert Committee. Hypertension control. WHO Technical Report Series 862. Geneva: World Health Organization, 1996

  17. Pardell H, Tresserras R, Saltó E, et al. Management of the hypertensive patient who smokes. Drugs 1998; 56(2): 177–87

    Article  PubMed  CAS  Google Scholar 

  18. Kaplan NM. Clinical hypertension. 6th ed. Baltimore: Williams & Wilkins, 1994: 50

    Google Scholar 

  19. Pardell H, Armario P, Hernández R, et al. Hypertension. Epidemiology and cost of illness. Dis Manage Health Outcomes 1997; 1: 135–40

    Article  Google Scholar 

  20. Study on Hypertension Control Monitoring at Community Level. Copenhagen: WHO Regional Office for Europe, 1994

  21. Whelton PK. Epidemiology of hypertension. Lancet 1994; 344: 101–6

    Article  PubMed  CAS  Google Scholar 

  22. Murray CJL, Lopez A. The global burden of disease. Cambridge, MA: Harvard University Press, 1996: 314

    Google Scholar 

  23. Dustan HP, Roccella EJ, Garrison HH. Controlling hypertension. A research success story. Arch Intern Med 1996; 156: 1926–35

    Article  CAS  Google Scholar 

  24. Ménard J, Cornu PH, Day M. Cost of hypertension treatment and the price of health. J Human Hypertens 1992; 6: 447–58

    Google Scholar 

  25. Schauffler H, D’Agostino R, Kannel WB. Risk for cardiovascular disease in the elderly and associated costs: the Framingham Study. Am J Prev Med 1993; 9: 146–54

    PubMed  CAS  Google Scholar 

  26. Holloway RG, Witter Jr DM, Lawton KB, et al. Inpatient costs of specific cerebrovascular events at five academic medical centers. Neurology 1996; 46: 854–60

    Article  PubMed  CAS  Google Scholar 

  27. Kannel WB, McGee D, Gordon T. A general cardiovascular risk profile: the Framingham Study. Am J Cardiol 1976; 38: 46–51

    Article  PubMed  CAS  Google Scholar 

  28. Kannel WB. Blood pressure as a cardiovascular risk factor. Prevention and treatment. JAMA 1996; 275: 1571–6

    CAS  Google Scholar 

  29. Massie BM, Shah NB. Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management. Am Heart J 1997; 133: 703–12

    Article  PubMed  CAS  Google Scholar 

  30. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke and coronary heart disease. Pt I. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765–74

    CAS  Google Scholar 

  31. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease. Pt 2. Effects of short term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet 1990; 335: 827–38

    Article  PubMed  CAS  Google Scholar 

  32. Whisnant JP, Wiebers DO, O’Fallon WM, et al. A population-based model of risk factors for ischemic stroke: Rochester, Minnesota. Neurology 1996; 47: 1420–8

    Article  PubMed  CAS  Google Scholar 

  33. Caspary L. Epidemiology of vascular disease. Dis Manage Health Outcomes 1997; 2 Suppl. 1: 9–17

    Article  Google Scholar 

  34. Last JM, editor. A dictionary of epidemiology. 3rd ed. New York: Oxford University Press, 1995: 145

    Google Scholar 

  35. Strasser T. Prévention cardiovasculaire: limites de la pharmacothérapie de l’hypertension artérielle. Med Soc Prév 1983; 28: 216–7

    Article  Google Scholar 

  36. Gordis L. Estimating risk and inferring causality in epidemiology. In: Gordis L, editor. Epidemiology and health risk assessment. New York: Oxford University Press, 1988: 51–60

    Google Scholar 

  37. Jackson R, Barham P, Bills J, et al. Management of raised blood pressure in New Zealand: a discussion document. BMJ 1993; 307: 107–10

    Article  PubMed  CAS  Google Scholar 

  38. Simpson FO. Guidelines for antihypertensive therapy: problems with a strategy based on absolute cardiovascular risk. J Hypertens 1996; 14: 683–9

    Article  PubMed  CAS  Google Scholar 

  39. Positioning CINDI to meet the challenges. A WHO/CINDI policy framework for noncommunicable disease prevention. Copenhagen: WHO Regional Office for Europe, 1992

    Google Scholar 

  40. Prevention in primary care. Recommendations for promoting good practice. Copenhagen: WHO Regional Office for Europe, 1995

    Google Scholar 

  41. Workshop on hypertension control in the community: policy, strategies, monitoring and evaluation. Report on a WHO consultation (Barcelona, 27 Feb–1 Mar 1994). Copenhagen: WHO Regional Office for Europe, 1995

Download references

Author information

Authors and Affiliations

  1. Service de Médecine Interne, Unité d’Hypertension et de Risque Cardiovasculaire, Red Cross Hospital, Hospitalet de Llobregat, Ave José Molins, 29-41, 08906, Barcelone, Espagne

    H. Pardell, P. Armario & R. Hernández

Authors
  1. H. Pardell
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Armario
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Hernández
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pardell, H., Armario, P. & Hernández, R. Pathogénie et épidémiologie de l’hypertension artérielle. Drugs 56 (Suppl 2), 1–10 (1998). https://doi.org/10.2165/00003495-199856002-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199856002-00001

Search

Navigation